(Reuters) By John Miller - Swiss drugmaker Roche Holding AG's new immunotherapy, Tecentriq (atezolizumab), won approval on Tuesday from U.S. health regulators as a second-line lung cancer treatment, a decision seen likely to erode Bristol-Myers Squibb's position in this hotly contested marke

(Reuters Health)By Madeline Kennedy - Health might be its own reward, but even cash incentives only work in the short term to motivate people to exercise more and activity trackers add little benefit, according to a study from Singapore."Readers should not assume that going out and buying a Fitbit

WASHINGTON (Reuters) By Reuters Staff - U.S. health officials outlined on Tuesday how they planned to divide up $1.1 billion in funds approved by Congress to fight the Zika virus, including repaying $44.25 million they were forced to borrow from a fund allocated for other emergencies. The funds were

(Reuters) By Caroline Humer and Emily Stephenson - When former President Bill Clinton called parts of Obamacare "crazy," he put his wife Hillary Clinton on the defensive and gave much-needed ammunition to her Republican rival for the presidency, Donald Trump, who wants to scrap it.Bill Clinton sai

NEW YORK (Reuters Health) By Will Boggs MD - The multipeptide cancer vaccine IMA901 does not improve survival when added to sunitinib in patients with metastatic renal cell carcinoma, according to results from the IMPRINT trial."Sunitinib monotherapy remains a standard of care," Dr. Brian I. Rini

WASHINGTON (Reuters) By Reuters Staff - U.S. Vice President Joseph Biden's Cancer Moonshot initiative to speed the develop of cancer treatments has made some important strides such as increased information sharing among researchers but still faces challenges in many areas, according to a report

(Reuters) By Jim Finkle - Medical-device maker St. Jude Medical Inc said on Monday that it planned to set up a medical advisory board focused on cyber-security issues affecting patient care and safety.St. Jude said in a statement that the group, known as the Cyber Security Medical Advisory Board, wo

(Reuters Health) By Kathryn Doyle - Commercial fitness trackers worn on the wrist are less accurate than a chest strap monitor at measuring heart rate, and may over- or underestimate heart rate depending on activity level, researchers say.In general, wrist monitors are more accurate at rest than dur

NEW YORK (Reuters Health) By Will Boggs MD - A new model based on routine pathologic parameters accurately estimates the need for gene expression profiling in women with early-stage breast cancer."Our key result was that the Oncotype DX (ODX) risk category can be reliably predicted, using standard

NEW YORK (Reuters Health) By Anne Harding - Injectable aripiprazole lauroxil is equally effective in adults with schizophrenia regardless of age or gender, a new post-hoc analysis shows."It is a useful intramuscular medication for all age groups," Dr. Steven Targum of Clintara LLC in Boston, the f

NEW YORK (Reuters Health)By Reuters Staff - LixiLan (Sanofi), a fixed-ratio combination of insulin glargine (100 units) and lixisenatide (Lixi, Sanofi), shows advantages over insulin glargine in certain patients with poorly controlled type 2 diabetes, according to new research.The study, online Sept

NEW YORK (Reuters Health)By Reuters Staff - LixiLan (Sanofi), a fixed-ratio combination of insulin glargine (100 units) and lixisenatide (Lixi, Sanofi), shows advantages over insulin glargine in certain patients with poorly controlled type 2 diabetes, according to new research.The study, online Sept

NEW YORK (Reuters Health)By David Douglas - Alectinib (Alecensa, Genentech) shows efficacy against CNS metastases in crizotinib-refractory patients with anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC), according to pooled data from two phase II studies sponsored by Hoffm

NEW YORK (Reuters Health)By Reuters Staff - A careful baseline evaluation of the risk of fracture is needed in all premenopausal women with breast cancer and in postmenopausal women initiating treatment with an aromatase inhibitor (AI), the European Menopause and Andropause Society (EMAS) advises in

(Reuters)By Reuters Staff - Drugmaker Intercept Pharmaceuticals Inc's drug to treat a rare liver condition was conditionally approved an advisory committee to the European Medicines Agency on Friday.The company's obeticholic acid, or Ocaliva, is aimed at patients with primary biliary cholang

(Reuters)By Reuters Staff - AbbVie Inc won the conditional backing of an advisory committee of the European Medicines Agency (EMA) on Friday for a drug to treat a form of blood cancer.The drug, venclyxto, or venetoclax, is aimed at chronic lymphocytic leukaemia (CLL) patients with a genetic mutation

(Reuters)By Reuters Staff - The Centers for Disease Control and Prevention said on Thursday open-heart surgery patients were at risk of acquiring life-threatening bacterial infections due to contamination of certain devices used in the surgery.The warning follows information indicating that some of

NEW YORK (Reuters Health) By Will Boggs MD- A new report stokes hopes that everolimus may prolong survival in patients with advanced pancreatic neuroendocrine tumors (NETs), but offers no clear answers.Based on these findings as well as "recent results from RADIANT4 published in Lancet, everolimus

NEW YORK (Reuters Health)By Will Boggs MD - A new clinical practice guideline from the Endocrine Society addresses the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes and places added emphasis on education."Tools such as pumps and sensors wo

COPENHAGEN (Reuters) By Ben Hirschler - Evelyn O'Flynn still has lung cancer. But after going straight on to a new immune system-boosting drug more than a year ago, rather than traditional hard-to-tolerate chemotherapy, she is feeling great."It's like a miracle," said the 72-year-old ex-sm